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Abstract
Background: As pressure ulcers contribute to significant patient burden and increased health care costs, their
prevention is a clinical priority. Our team developed and tested a complex intervention, a pressure ulcer prevention
care bundle promoting patient participation in care, in a cluster-randomised trial. The UK Medical Research Council
recommends process evaluation of complex interventions to provide insight into why they work or fail and how
they might be improved. This study aimed to evaluate processes underpinning implementation of the intervention
and explore end-users’ perceptions of it, in order to give a deeper understanding of its effects.
Methods: A pre-specified, mixed-methods process evaluation was conducted as an adjunct to the main trial,
guided by a framework for process evaluation of cluster-randomised trials. Data was collected across eight
Australian hospitals but mainly focused on the four intervention hospitals. Quantitative and qualitative data were
collected across the evaluation domains: recruitment, reach, intervention delivery and response to intervention, at
both cluster and individual patient level. Quantitative data were analysed using descriptive and inferential statistics.
Qualitative data were analysed using thematic analysis.
Results: In the context of the main trial, which found a 42% reduction in risk of pressure ulcer with the intervention
that was not significant after adjusting for clustering and covariates, this process evaluation provides important insights.
Recruitment and reach among clusters and individuals was high, indicating that patients, nurses and hospitals are
willing to engage with a pressure ulcer prevention care bundle. Of 799 intervention patients in the trial, 96.7% received
the intervention, which took under 10 min to deliver. Patients and nurses accepted the care bundle, recognising
benefits to it and describing how it enabled participation in pressure ulcer prevention (PUP) care.
Conclusions: This process evaluation found no major failures relating to implementation of the intervention. The care
bundle was found to be easy to understand and deliver, and it reached a large proportion of the target population
and was found to be acceptable to patients and nurses; therefore, it may be an effective way of engaging patients in
their pressure ulcer prevention care and promoting evidence-based practise.
Keywords: Care bundle, Cluster-randomised trial, Complex intervention, Patient participation, Pressure injury
prevention, Pressure ulcer prevention, Process evaluation
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Background
Pressure ulcer (PU) affects around 10–30% of hospitalised
patients worldwide [1–4] and contributes to significant
patient burden [5, 6] and health care costs [7]. PUs increase
hospital length of stay [8] and treatment costs across Aus-
tralian public hospitals were estimated at A$983 million per
year, representing 1.9% of all public hospital expenditure in
2012–2013 [9]. The majority of PUs in the clinical setting
are hospital-acquired pressure ulcers (HAPU) [10–12],
most of which are preventable [13–15]. As such, many
health care organisations around the world have imple-
mented financial penalties such as withdrawal of reim-
bursement or fines to hospitals for HAPU [16–18].
Pressure ulcer prevention (PUP) is also one of the national
health service standards set by the Australian Commission
on Safety and Quality in Health Care [13], highlighting the
importance of this clinical issue.
Evidence suggests that patient outcomes can be improved
and adverse events reduced through the use of multi-
component interventions, or care bundles [19–22] and
patient participation in care [23]. Therefore, an innovative
PUP care bundle (PUPCB) was developed by our research
team to reduce HAPU in patients at high risk of developing
PU [24]. The INTroducing A Care bundle To prevent pres-
sure ulcer (INTACT) trial was a pragmatic cluster-
randomised trial (c-RT) assessing the effect of a PUPCB on
the development of PU in hospitalised patients deemed at
risk of PU (i.e. with reduced mobility) [25]. Eight Australian
hospitals were randomised to receive the intervention or
control. The intervention was aimed at both the cluster
(nurse) and individual (patient) level, focusing on patient
participation in care and partnerships between patients and
nurses in PUP. The PUPCB was delivered to patients by a
trained research assistant and included a brochure, poster
and DVD, all of which contained three key messages: (1)
keep moving; (2) look after your skin; and (3) eat a healthy
diet. These messages did not vary between different patient
groups and were based on current literature and inter-
national evidence-based guidelines, which indicate that
immobility, poor skin hydration and malnutrition are modi-
fiable risk factors for PU [26–29]. If patients’ relatives were
present at the time of intervention delivery, they would
have also received the information; however, they were not
specifically targeted. The cluster-level intervention involved
information sessions delivered to nursing staff on study
wards, who were given education and training around PUP,
the PUPCB, and partnering with patients in PUP care. Fur-
ther detail on the theory underpinning the intervention and
study methods are reported elsewhere [24, 25].
Care bundles are multifaceted, containing a number of
interacting components; they depend on the social
context and behaviours of those delivering or receiving
the intervention and may target a number of groups or
organisational levels [30, 31]. Due to these complexities,
such interventions pose methodological challenges, and
study outcomes (i.e. intervention success or failure) may
be affected by factors related to the implementation or
delivery of an intervention [30]. Therefore, evaluation of
the processes related to intervention delivery is import-
ant to provide insight into why interventions work or fail
and how they can be improved [30]. Process evaluation
is especially important in multisite trials where the same
intervention may be implemented and received in differ-
ent ways [31].
The aim of this study was to evaluate the processes
underpinning implementation of the PUPCB and patient
and staff perceptions of the bundle in order to give a
deeper understanding of the effects of the intervention.
Methods
Study design
A pre-specified mixed-methods process evaluation was
conducted as an adjunct to the INTACT study, guided
by a framework for c-RTs described by Grant et al. [32].
A number of aspects comprised the process evaluation,
as described in Table 1. Recruitment and reach, inter-
vention delivery, acceptability of the intervention and
potential for maintenance of the intervention (i.e. in
standard care) were all measured at the cluster and indi-
vidual levels, using a mix of quantitative and qualitative
approaches. These were interpreted with consideration
of context and in relation to the main trial’s findings.
Setting and sample
Eight Australian hospitals participated in the INTACT
trial, and data for the process evaluation was collected
across all sites, but focused mainly on the four interven-
tion sites. Participants included patients and nurses on
study wards at intervention sites, but some data (such as
recruitment data) was also collected on patients at
control sites. For qualitative data collection, patients and
nurses provided individual informed consent to partici-
pate in interviews.
Data collection
Quantitative data were collected mostly prior to and
during the intervention, whilst qualitative data were
collected post-intervention. Equal emphasis was given to
quantitative and qualitative data, which complemented
each other in terms of interpreting findings. The
research questions, research methods and data collection
techniques for each evaluation domain are described in
Table 1.
Data analysis
Recruitment and reach
The representativeness of clusters was assessed qualita-
tively by comparing hospital type, location, services and
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size to all Australian hospitals using Australian Institute
of Health and Welfare statistics. Recruitment of individ-
uals was assessed by comparing the total numbers of pa-
tients screened and recruited at each site to determine
the proportion of the target population included in the
study. This evaluation domain was assessed to provide
insight into the sample and its representativeness.
Intervention delivery
Data on intervention delivery to clusters were analysed
descriptively (i.e. number of sessions delivered, number
of staff present at each session, time spent delivering
each session, who delivered it and when it was delivered
in relation to the study timeline). Intervention delivery
to patients (i.e. components of the PUPCB delivered and
time spent with patients) were analysed descriptively.
Chi-squared tests and one-way analysis of variance
(ANOVA) tests were used to determine any differences
in intervention delivery between sites. The effects of
intervention dose on main trial findings were also ana-
lysed at the individual patient level using chi-squared
tests (i.e. number of intervention components delivered)
Table 1 Components and methods of process evaluation, adapted from Grant et al. [31]
Evaluation domain Research questions Research methods Data collection tools
Recruitment of
clusters
How are clusters sampled and
recruited? Are they representative?
Descriptive analysis of recruited clusters
and their representativeness
Hospital demographics were collected by
CIs at each site
Recruitment and
reach in
individuals
Who actually receives the intervention
in each setting? Are they
representative?
Descriptive analysis of screening log
data
Recruiting RAs at each site recorded total
number of patients screened vs. total number
of patients recruited and barriers to
participation, reasons for dropout
Delivery to
clusters
What intervention is actually delivered
to each cluster? Is it the one intended
by researchers?
Descriptive analysis of intervention
delivery (i.e. training sessions) to nursing
staff at each site
CIs kept a log of information sessions
delivered to nursing staff at each site,
including number of participants and time
spent at each session, who delivered the
session and when (in relation to study
timeline)
Delivery to
individuals
What intervention is actually delivered
to individuals? Is it the one intended
by researchers?
Descriptive analysis of intervention
delivery (i.e. DVD, brochure, poster)
Interventionist RAs recorded which
intervention components were delivered to
each patient and total time spent with each
patient
Response of
clusters
How is the intervention adopted by
clusters?
Qualitative analysis of nurse interviews A semi-structured interview guide was used to
explore nurses’ perspectives of the intervention
(four to five nurses per intervention site)
(citation masked for peer review)
Response of
individuals
How does the target population
respond?
Qualitative analysis of patient interviews A semi-structured interview guide was used
to explore patients’ perspectives of the
intervention (four to five patients per
intervention site) (citation masked for
peer review)
Maintenance How and why are these processes
sustained over time (or not)?
Qualitative analysis of nurse and patient
interviews
See above (for nurses and patients)
Effectiveness What are the effects on primary and
secondary outcomes?
Exploratory analyses of effect of trial
processes (i.e. above domains) on trial
outcomes
Main findings from the INTACT trial and results
from above process evaluation domains
comprised data for these analyses. However,
the study was not powered for these
exploratory analyses
Unintended
consequences
Are there unintended changes in
processes and outcomes, both related
to the trial intervention and unrelated
care?
Qualitative analysis of observed data,
qualitative analysis of patient and staff
interviews
Semi-structured interview guides and
observational tools/logs (described above)
Context What is the wider context in which
the trial is being conducted?
Consideration of state and national
contexts of each hospital setting
regarding PUP (i.e. national standards,
state penalties, hospital policies and
procedures) when interpreting findings
Literature search of local, state and national
hospital standards, policies and procedures
relating to PUP
Theory What theory has been used to
develop the intervention? Can a
theory be considered to interpret the
effects of the intervention?
N/A–consideration of theory used to
develop the intervention was considered
in interpretation of findings. Additional
theories were sought to explain findings
of each component of the process evaluation
CIs chief investigators, RAs research assistants
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and one-way ANOVA tests (i.e. time spent delivering
intervention) to describe any associations between inter-
vention delivery and PU development.
Response to intervention
Semi-structured interview data on responses of clusters (i.e.
nurses) and individuals (i.e. patients) to the intervention
were analysed qualitatively using thematic analysis to give
in-depth insights into patients’ and nurses’ perceptions of
the intervention. More detailed methods of patient and staff
interviews are reported elsewhere (citations masked for
peer review).
Results
The outcomes of the INTACT trial are reported else-
where (citation masked for peer review); however, for
the purpose of this process evaluation, a summary of the
main trial findings are presented. PU occurred in 6.1% of
intervention and 10.5% of control patients, and PU inci-
dence was 9.6 and 20.1 per 1000 person-days in the
intervention and control groups, respectively (incidence
rate ratio 0.48; 95% CI 0.33, 0.69; p < 0.001). After
adjusting for clustering and covariates (age, baseline PU,
body mass index, admission cause, residence and comor-
bidities), the hazard ratio was 0.58 (42% risk reduction,
p = 0.198). However, the intra-class correlation coeffi-
cient was higher than expected (i.e. higher than that
used to calculate sample size) so it is likely the study
was underpowered. There are other possible reasons for
these results, such as potential baseline differences, or
the delivery of the intervention which is the focus of this
evaluation.
Recruitment of clusters
Clusters were recruited using a convenience sample of
hospitals meeting the study’s inclusion criteria, detailed
elsewhere (citation masked for peer review). The study in-
cluded eight hospitals representing health services across
three states in Australia. Six public (75%) and two private
(25%) hospitals were included in the study, which is simi-
lar to the total split of public (72%) and private (28%) hos-
pitals across Australia [33]. Hospitals were metropolitan
(n = 7) or regional (n = 1) and were either tertiary (n = 5),
quaternary (n = 2) or tertiary, providing quaternary ser-
vices (n = 1), reflecting the range in Australian hospitals.
The size of study sites ranged from 270 to 929 beds (me-
dian 565, IQR 355–737 beds) and 8–28 wards (median 18,
IQR 10–23 wards). Between four and 12 medical, surgical
and rehabilitation wards (median 7, IQR 4–9 wards) were
included in the INTACT trial across study sites.
Recruitment and reach in individuals
The target population was patients who met eligibility
criteria for inclusion in the study. The proportion of the
total target population that was included in the study
was 67.2%. Table 2 shows the total number of eligible
patients and the numbers and proportion of refusing,
consenting and included patients in the INTACT trial,
which were similar between groups.
Intervention delivery to clusters
At the cluster level, the intervention was delivered to
nurses on study wards. All four intervention sites held for-
mal information sessions for nurses using a standardised
PowerPoint presentation and study flyers, containing
information on the intervention and partnering with pa-
tients in PUP. Between four and eight, formal sessions
were conducted at each site (depending on the number of
study wards at that site) prior to and during data collec-
tion, reaching 38–66 participants at each site. Formal
inservices lasted 15–30 min and were delivered by the site
Chief Investigator or a research assistant at each study
site. In addition, all sites conducted informal sessions with
nurses on study wards, which included an overview of the
information presented in formal sessions. These informal
sessions were conducted ad hoc, at times of convenience
to ward staff, and may have been delivered to staff one-
on-one or in groups. Due to the ad hoc nature of these in-
formal sessions, it was difficult to quantify the number of
nurses reached, but there were at least 30 informal ses-
sions delivered at each site. These tended to be shorter
than the formal presentations (around 3–10 min). While
all clusters received a similar dose of the intervention in
terms of content, frequency and time, individual nurses
may have been missed and it was a one-off training ses-
sion without ongoing support.
Intervention delivery to individuals
Of the 799 intervention patients included in the study,
773 (96.7%) received at least one component of the
intervention while 690 (86.4%) received all three compo-
nents (i.e. brochure, poster and DVD). Table 3 shows the
number of patients who received each component of the
intervention across all sites. There were no significant
differences in the proportion of patients who received
each intervention component between sites.
Of the 26 participants that did not receive the inter-
vention after consent, reasons included the patient being
Table 2 Recruitment of patients
Enrolment procedure Intervention
n (%)
Control
n (%)
Total
n (%)
Eligible 1209 1168 2377
Refused 409 (33.8) 368 (31.5) 777 (32.7)
Consented 800 (66.2) 800 (68.5) 1600 (67.3)
Includeda 799 (66.1) 799 (68.4) 1598 (67.2)
aOne patient in each group was excluded after giving consent, as they met
exclusion criteria (i.e. were confused)
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discharged (n = 8) or too sick (n = 1), or the patient re-
fused (n = 5) or withdrew from the study (n = 4), or data
was missing (n = 3) or listed as ‘other’ reason (n = 5).
The mean (±SD) time spent delivering the interven-
tion to each patient was 9.5 ± 5.4 min (range 0–45 min,
median 8.0, IQR 7.0–11.0 min). There was a significant
difference in time spent on intervention delivery
between sites, using a one-way ANOVA (p < 0.001) and
Tukey post hoc test (p < 0.001), as shown in Table 4.
The amount of time spent delivering the intervention
was also related to the number of components delivered
(see Table 4). Interestingly, the most time was spent
when patients only received one resource.
Response of clusters
A total of 18 nursing staff participated in interviews
across the four intervention sites. Nurses’ perceptions of
the intervention were expressed in five categories: (1)
awareness of the pressure ulcer prevention care bundle
and its similarity to current practise; (2) improving
awareness, communication and participation with the
pressure ulcer prevention care bundle; (3) appreciating
the positive aspects of patient participation in care; (4)
perceived barriers to engaging patients in the pressure
ulcer prevention care bundle; and (5) partnering with
nursing staff to facilitate pressure ulcer prevention care
bundle implementation. Nurses responded well to the
PUPCB when they thought it reflected or supported
their current PUP practise. They realised benefits to
both the PUPCB and patient participation in general,
and this increased their acceptance for both. Nurses also
provided insights into implementation and sustainment
of such an intervention in practise; they spoke about com-
munication and dissemination of results, the importance
of leadership and influence and keeping the bundle simple
to deliver. A detailed analysis of clusters’ response to the
intervention is reported elsewhere (citation masked for
peer review).
Response of individuals
A total of 19 patients participated in interviews across the
four intervention sites. There was a range of responses to
the intervention among patients, who provided feedback
on the intervention itself and described how they did or
did not participate in PUP care. Participants’ perceptions
of their experience with the intervention were described
in three themes/categories: (1) importance of personal
contact in PUPCB delivery; (2) understanding PUP
enhances participation; and (3) individual factors impact
patients’ engagement in PUP. Patients particularly
highlighted the importance of human interaction in facili-
tating engagement with the PUPCB. An unintended con-
sequence of the study was that study outcome assessors
acted as a reminder to patients to enact PUP strategies.
Patients responded well to the intervention when they
thought it reinforced what they already knew or did. They
described how improved knowledge and awareness of
PUP empowered and motivated them to participate in
PUP care. They also discussed barriers to participation,
which included low-perceived importance of PUP and
personal factors such as age, cognition and mobility. Fur-
ther detail on findings from patient interviews are re-
ported elsewhere (citation masked for peer review).
Discussion
This process evaluation provides important insights into
the implementation of a PUPCB and in interpretation of
the INTACT trial’s findings. Recruitment and reach was
broad, providing a good representation of patients and
hospitals; intervention delivery to individuals and clus-
ters was consistently high across sites; and patients and
nurses responded positively to the intervention. This
shows promise for ease of implementation of a patient-
centred PUPCB. The main trial found that intervention
patients developed significantly less PU at the cluster
level; however, this finding was not significant at the in-
dividual patient level after adjusting for covariates and
clustering (citation masked for peer review). As this
process evaluation showed no major failures relating to
implementation of the intervention, this lack of statis-
tical significance at the patient level may be due to the
study being underpowered rather than inadequate
implementation processes. There are also various other
potential reasons for the main study findings, as
discussed in the INTACT trial paper [25].
Table 3 Intervention delivery to individuals
Site Brochure
n (%)
Poster
n (%)
DVD
n (%)
All components
n (%)
1 193 (97.0) 185 (93.0) 174 (87.4) 167 (83.9)
2 193 (96.5) 187 (93.5) 180 (90.0) 176 (88.0)
3 192 (96.0) 192 (96.0) 171 (85.5) 171 (85.5)
4 192 (96.4) 194 (97.0) 180 (90.0) 176 (88.0)
Total 770 (96.4) 758 (94.9) 705 (88.2) 690 (86.4)
Table 4 Time spent delivering intervention to patients
Site Time (min)
mean ± SD
Number of components
received
Time (min)
mean ± SD
1 11.0 ± 6.7* 0 0.1 ± 0.4***
2 13.3 ± 5.3* 1 15.7 ± 25.4****
3 6.6 ± 2.5** 2 5.3 ± 5.6***
4 7.2 ± 2.4** 3 10.3 ± 4.6****
Total 9.5 ± 5.4
*Different from all other sites (p < 0.05)
**Different from sites 1 and 2 (p < 0.05)
***Different from all other numbers of components received (p < 0.05)
****Different from 0 to 2 components received (p < 0.05)
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High recruitment and reach of clusters and individuals
suggests that both patients and nurses were willing to
engage in an intervention encouraging patient participa-
tion in PUP care and nurse-patient partnership. This is
consistent with two Australian studies that found the
majority of patients they interviewed or surveyed wanted
to play a proactive role in PUP in hospital [34, 35]. In
the context of Australian health care, some of which
have incentive or penalty programs in place to reduce
PU [13, 16]; it is clearly in hospitals’ best interests to
participate in PUP interventions. Patient engagement
and PUP are two of the Australian Commission on
Safety and Quality in Health Care’s national safety and
quality health service standards [13], and are also in line
with international PUP clinical practise guidelines [26],
which may have contributed to the high participation
rate of hospitals in the trial. Due to the broad represen-
tation of hospitals and wards, it appears the PUPCB may
be practical and feasible in a variety of Australian hospi-
tals. Similarly, the fact that two thirds of the target
population (i.e. of eligible patients) participated in the
study means that a wide range of patients were repre-
sented and were willing to engage with the care bundle.
This is consistent with two Australian studies that found
the majority of patients they interviewed or surveyed
wanted to play a proactive role in PUP in hospital [34,
35]. In retrospect, it would be interesting to better
understand why one third of patients declined to
participate.
The intervention was implemented and delivered as
intended, and all clusters received the intervention
(nursing staff training) in a similar way in terms of con-
tent, dose and delivery. A range of training delivery
methods were used to inform nurses about the PUPCB
and instruct them in partnering with patients in PUP
care. It is well recognised in theories of adult learning
that multiple modes of delivery are important to accom-
modate for different individuals’ learning styles and pref-
erences [36]. Patients also received information in
different visual formats as well as verbal communication.
Most patients (97%) received at least one component of
the intervention, and 86% received all three components.
Interestingly, the most time was spent when patients
only received one component of the bundle. Perhaps pa-
tients were more engaged or asked more questions when
they just had one resource to focus on. Or, perhaps this
time, difference reflects the way the individual research
assistants (RAs) approached their delivery of the inter-
vention. Given individuals have different learning styles,
it is reasonable that patients may not need to receive all
components of the intervention for it to have an effect.
This is consistent with the concept of minimally disrup-
tive care, which proposes interventions should be priori-
tised so patients are less burdened and hence more
likely to adhere to the important components [37].
Congruently, tailored interventions seek to customise in-
formation or strategies to individuals’ characteristics,
needs and preferences [38, 39]. Systematic and integra-
tive reviews have found tailored interventions are more
likely to be effective and are preferred by participants
compared to standard interventions [40, 41]. Future
considerations for implementation of the PUPCB may
include assessing patients’ learning preferences and
tailoring the content or mode of delivery based on this;
for example, some patients may prefer a combination of
materials, whilst others may rather have a conversation
about the content. Also, messages may need to be rein-
forced with follow-up doses for patients and ongoing
support for nurses around the PUPCB.
Nurses and patients generally responded positively to
the intervention (citations masked for peer review).
Nurses recognised benefits of the PUPCB to both
patients and nurses, with improved awareness, commu-
nication and participation related to PUP care. Nurses
offered suggestions for implementation and maintenance
in practise, which included partnering with nurses
through communication and dissemination of evidence
(both existing evidence and the trial’s findings); leader-
ship and influence (through internal and external facili-
tators); and keeping the bundle simple (with minimal
paperwork and tasks required for PUPCB delivery)
(citation masked for peer review). As nurses’ perceptions
of an intervention are likely to influence its uptake and
use in clinical practise and in turn, its effect [42], their
thoughts of the PUPCB were important to explore as
part of the INTACT trial’s process evaluation. Nurses’
responses to the PUPCB indicated it may be an accept-
able way to implement evidence-based PUP guidelines
and engage patients in PUP care.
The patient interview component of the process evalu-
ation found that overall, patients responded positively to
the PUPCB and described how learning about PUP
empowered them to participate in PUP care (citation
masked for peer review). Patients particularly enjoyed
interacting with the research assistants (interventionists
and outcome assessors). Some patients had trouble
remembering information from the education materials,
or said they preferred and remembered more from the
discussion with the interventionist. This indicates some
patients may have benefited from a top-up dose of the
intervention to reinforce the messages. Further, outcome
assessors acted as a reminder to patients to enact PUP
strategies, which was an unintended consequence of the
study. However, evaluation was consistent across inter-
vention and control patients, and so, any effect outcome
assessors had on the behaviour of intervention patients
is likely due to their presence reminding patients of the
information they received in the PUPCB. As the care
Roberts et al. Implementation Science  (2017) 12:18 Page 6 of 9
bundle is intended to be delivered by nurses in actual
practise, and nurses perform routine skin assessments,
this unintended consequence could actually be positive
as it mirrors what would likely occur if the PUPCB was
adopted into routine practise. That is, nurses’ presence
while performing skin assessments may remind patients
to enact PUP strategies if they have previously received
the PUPCB. Some patients said they preferred a more
interactive style of learning, such as through programs
on handheld tablets. The role of technology in health
care is increasing, and it may be an effective platform by
which to engage hospitalised patients in their care
(citation masked for peer review). This is an important
consideration for future implementation of the PUPCB.
A key strength of the PUPCB was the strong theoret-
ical framework and valid evidence underpinning it. The
Medical Research Council (MRC) recommends complex
interventions to have strong theoretical foundations and
be evidence-based [30]. The PUPCB was informed by
the concepts of patient participation in care, which were
evident through the following: (1) the focus on building
a strong nurse-patient relationship; (2) meaningful
exchange of PUP information; (3) training nurses in sur-
rendering some power/control to enable patients to par-
ticipate in PUP care; and (4) training nurses and patients
in mutual/shared decision-making and participation in
physical/intellectual care activities [43]. Intervention
strategies were also informed by PUP clinical practise
guidelines [44] and five systematic reviews on PUP [19–
21, 29, 45]. In line with the MRC framework [30], the
intervention underwent feasibility testing and piloting to
test procedures, estimate recruitment and retention
rates, calculate sample sizes and assess patient and nurse
acceptability [46, 47]. Patients’ and nurses’ responses to
the intervention indicate behaviour change is likely to
occur through factors consistent with Rogers’ ‘diffusion
of preventative innovations’ theory [48]. Both patients
and nurses responded well to the intervention when they
found it simple (low complexity), when it aligned with
their current knowledge or practises (compatibility) and
when they saw benefits to it (relative advantage).
Other process evaluations of cluster-randomised trials
using Grant’s framework [32] are of variable rigour and
quality. For example, Wallace et al. only assessed one
domain of the framework, individuals’ responses to the
intervention, using only qualitative methods [49]. Clyne
et al. did not clearly describe which domains were evalu-
ated in their process evaluation methodology, and whilst
they collected both quantitative and qualitative data,
they did not evaluate clusters’ and individuals’ response
to the intervention [50]. One protocol paper gave an in-
depth description of the intended use of the framework
for their process evaluation, covering all evaluation
domains and clearly describing methods of assessing
each, using a combination of quantitative and qualitative
data [51]; however, it appears the study is yet to be con-
ducted. Our study is the first to our knowledge to use
Grant et al.’s framework in its entirety (i.e. covering all
evaluation domains) for process evaluation of a cluster-
randomised trial.
Our study provides important insights into conducting
process evaluations for c-RTs using the framework pro-
posed by Grant et al. [32]. Firstly, we recommend
process evaluations be conducted a priori, like this one;
however we still did not anticipate some of the data that
may be needed for further analysis. For example, the
study was not powered for exploratory analyses testing
for associations between intervention dose/delivery and
main trial outcomes, such as development of a PU. If re-
searchers wish to test for these associations, this needs
to be considered in the design of the main trial. In our
case, increasing the sample size of the main trial for this
type of exploratory analyses was not feasible. So, whilst
the framework suggests these be conducted, their useful-
ness and/or feasibility may be limited in some instances.
Secondly, a comprehensive process evaluation like this
one that covers all domains of the framework is resource
intensive. Researchers must consider the budget and
time needed for a process evaluation before applying for
funding for the main trial. Finally, the role of the process
evaluator is important. In this study, the process evalu-
ator started as an independent assessor; but during
analysis of process evaluation data, this role expanded to
become part of the team evaluating the main trial, due
to the important insights gained from the process evalu-
ation in interpreting the main trial’s findings.
Conclusions
This study explored processes related to the implementa-
tion of a PUPCB intervention encouraging active patient
participation in PUP care and promoting nurse-patient
partnership. As there were no major failures relating to
implementation of the intervention, the lack of statistical
significance at the patient level in the main trial may be
due to the study being underpowered. The PUPCB was in-
formed by theory and evidence around PUP and patient
participation. It was easy to deliver (in less than 10 min)
and reach a large proportion of the target population.
Patients found it easy to understand, but they (and nurses)
may have benefited from a top-up dose (reinforcement) of
the intervention. Despite this, the PUPCB was found to be
acceptable to patients and nurses; therefore, it may be an
effective way of empowering patients to participate in
their PUP care and promoting evidence-based PUP
practise.
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